Renal & Urology News: Systemic Inflammation in ASCVD May Increase Risk of Major Kidney Outcomes Elevated CRP levels in patients with ASCVD should prompt clinicians to screen and monitor patients for kidney injury. Elevated C-reactive protein levels in patients with atherosclerotic cardiovascular ... The American Journal of Managed Care: AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention The AMGA Foundation's initiative focuses on secondary prevention of ASCVD using a population health approach to improve patient care and outcomes.
The framework provides evidence-based strategies for ... Patients with depression were diagnosed with atherosclerotic cardiovascular disease (ASCVD) earlier than those without depression and were more likely to be prescribed lipid-lowering therapy (LLT). Treatment for elevated blood lipid levels should begin much earlier and more aggressively to reduce the risk for atherosclerotic cardiovascular disease (ASCVD), according to an updated comprehensive ... Taking into account estimated 30-year risk of atherosclerotic cardiovascular disease (ASCVD) enables clinicians to identify which patients may benefit from starting primary-prevention strategies ...
ascvd symptoms, Panel (A) shows classifications based on the ASCVD Risk Estimator Plus, where 45% (209/465) of patients would not have qualified for statin therapy or further testing. Panel (B) displays results from ...
